Back to search

Article

Treatment of COVID-19 patients with a SARS-CoV-2-specific siRNA-peptide dendrimer formulation

2022-10-30

Abstract excerpt

BACKGROUND Severe acute respiratory syndrome corona virus (SARS-CoV-2) infection frequently causes severe and prolonged disease but only few specific treatments are available. We aimed to investigate safety and efficacy of a SARS-CoV-2-specific siRNA-peptide dendrimer formulation (MIR 19 ®) targeting a conserved sequence in known SARS-CoV-2 variants for treatment of COVID-19. METHODS We conducted an open-label, r...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
f8e8fbb8-0efb-5fee-b481-c6483c127e16
DOI
10.22541/au.166713666.61935503/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Treatment of COVID-19 patients with a SARS-CoV-2-specific siRNA-peptide dendrimer formulationDOI 10.22541/au.166713666.61935503/v1
Select a neighboring publication to make it the new centre.